Common use of EXPERTS Clause in Contracts

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We filed with the Commission a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statement. We file annual, quarterly, and current reports and other information with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Room.

EXPERTS. The consolidated financial statements of Monopar Therapeutics Inc. as of December 31, 2021 and 2020, and for each of the two years in the period ended December 31, 2021, incorporated in this Prospectus by reference into this prospectus to its Annual Report on Form 10-K for the year ended December 31, 2021, have been so included incorporated in reliance on the report of Xxxxxx BPM LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We have filed with the Commission SEC a shelf registration statement on Form S-3 under the Securities Act for with respect to the common stock in Common Stock we are offering by this offeringATM Prospectus. This prospectus ATM Prospectus does not contain all of the information included in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect pertaining to us and our common stockCommon Stock, we you should refer you to the registration statement and the exhibits that were filed with the registration statementto its exhibits. Statements contained Whenever we make reference in this prospectus about ATM Prospectus to any of our contracts, agreements or other documents, the contents of any contract or any other document that is filed as an exhibit to the registration statement references are not necessarily complete, and we you should refer you to the full text of the contract or other document filed as an exhibit exhibits attached to the registration statementstatement for copies of the actual contract, agreement or other document. We file annual, quarterly, quarterly and current reports reports, information statements and proxy statements and other information with the CommissionSEC. Our filings with You can read our SEC filings, including the Commission are available to registration statement, at the public on the CommissionSEC’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, copy any document we file with the CommissionSEC at its public reference facility at 000 X Xxxxxx, including the registration statement (X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000. We also maintain a website at xxxx://xxx.xxxxxxxxx.xxx. You may access, free of charge, our annual reports on Form 10-K, quarterly reports on Form 10- Q, current reports on Form 8-K and its exhibitsamendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of which the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained on, or that can be accessed through, our website is not a part of, and should not be construed as being incorporated by reference into, this prospectus is a part, ATM Prospectus You may also obtain copies of the documents at prescribed rates by writing to the Commission’s Public Reference Room located Section of the SEC at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for further information on the operation of the Public Reference Roompublic reference facilities.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLPVerb Technology Company, related to the consolidated financial statements Inc. as of and for the years ended June 30December 31, 2020 and 2019 and 2018appearing in Verb Technology Company, Inc.’s Annual Report on Form 10-K have been audited by Xxxxxxxx & Company, P.A., an independent registered public accounting firm, given on as stated in their report thereon, included therein, and are incorporated by reference in reliance upon such report and upon the authority of said such firm as experts in auditing accounting and accountingauditing. We have filed with the Commission SEC a registration statement on Form S-3 under the Securities Act for Act, and the rules and regulations promulgated thereunder, with respect to the shares of common stock in offered under this offeringprospectus. This prospectus prospectus, which constitutes a part of the registration statement, does not contain all of the information contained in the registration statement and the exhibits and schedule that were schedules thereto. Certain contracts and other documents described in this prospectus, and the documents incorporated by reference herein, are filed with as exhibits to the registration statement, and you may review the full text of these contracts and documents by referring to these exhibits. For further information with respect to us and our the shares of common stockstock offered under this prospectus, we refer you reference is made to the registration statement and the its exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementschedules. We file annual, quarterly, quarterly and current reports reports, proxy statements, and other information with the CommissionSEC. The SEC maintains a website that contains these reports, proxy and information statements, and other information we file electronically with the SEC. Our filings with the Commission are available to free of charge at the public on the CommissionSEC’s website at xxx.xxx.xxx. Those filings are also available to the public Our website address is xxxxx://xxx.xxxx.xxxx/. We maintain a section on our corporate website, xxxxx://xxx.xxxx.xxxx/investor-relations/sec-filings, through which you can obtain copies of the reports, proxy and information statements, and other information we file electronically with the SEC. We use our website xxxxx.xxxxxxx.xxxas a channel of distribution for material company information. Important information, including financial information, analyst presentations, financial news releases, and other material information about us is routinely posted on and accessible on our website. The information we file with the Commission or contained set forth on, or linked to throughaccessible from, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomprospectus.

EXPERTS. The financial statements incorporated by reference into as of December 31, 2018 and 2017, and for the years then ended, included in this prospectus Prospectus have been so included in reliance on the report of Xxxxxx BPM LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We have filed with the Commission a SEC this shelf registration statement on Form S-3 under the Securities Act for the common stock in with respect to our Common Stock we are offering by this offeringprospectus. This prospectus does not contain all of the information included in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect pertaining to us and our common stockCommon Stock, we you should refer you to the registration statement and the exhibits that were filed with the registration statementto its exhibits. Statements contained Whenever we make reference in this prospectus about to any of our contracts, agreements or other documents, the contents of any contract or any other document that is filed as an exhibit to the registration statement references are not necessarily complete, and we you should refer you to the full text of the contract or other document filed as an exhibit exhibits attached to the registration statementstatement for copies of the actual contract, agreement or other document. We file annual, quarterly, quarterly and current reports reports, information statements and proxy statements and other information with the CommissionSEC. Our filings with You can read our SEC filings, including the Commission are available to registration statement, at the public on the CommissionSEC’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, copy any document we file with the CommissionSEC at its public reference facility at 000 X Xxxxxx, including the registration statement (X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000. We also maintain a website at xxxx://xxx.xxxxxxxxx.xxx. You may access, free of charge, our annual reports on Form 10-K, quarterly reports on Form 10- Q, current reports on Form 8-K and its exhibitsamendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of which the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained on, or that can be accessed through, our website is not a part of, and should not be construed as being incorporated by reference into, this prospectus is a part, or the accompanying prospectus supplement. You may also obtain copies of the documents at prescribed rates by writing to the Commission’s Public Reference Room located Section of the SEC at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for further information on the operation of the Public Reference Roompublic reference facilities.

EXPERTS. The financial audited consolidated balance sheets as of September 30, 2013 and 2012, and the related consolidated statements of income and comprehensive income, shareholders’ equity, and cash flows for each of the years in the two-year period ended September 30, 2013 incorporated herein by reference into this prospectus from the Company’s Annual Reports on Form 10-K have been so included in reliance on the report of audited by Xxxxxx LLPand Company, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, Inc. an independent registered public accounting firm, as stated in its report, which is incorporated by reference and has been so incorporated in reliance upon the report of such firm given on the upon its authority of said firm as experts in auditing accounting and accountingauditing. We have filed with the Commission a registration statement under on Form S-3 with the Securities Act SEC for the common stock in securities we are offering by this offeringprospectus. This prospectus does not contain include all of the information contained in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we You should refer you to the registration statement and its exhibits for additional information. We will provide to each person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the exhibits information that were filed has been incorporated by reference in the prospectus but not delivered with the registration statementprospectus. Statements contained in We will provide this prospectus about the contents information upon oral or written request, free of any contract charge. Any requests for this information should be made by calling or any other document that is filed as an exhibit sending a letter to the registration statement are not necessarily complete, and we refer you to the full text Secretary of the contract or other document filed as an exhibit to Company, c/o LiveDeal, Inc., at the registration statementCompany’s office located at 000 X. Xxxx Xxxxxxx Xxxx, Xxxxx 000, Xxx Xxxxx, XX 00000. The Company’s telephone number is 000-000-0000. We are required to file annualannual and quarterly reports, quarterlycurrent reports, and current reports proxy statements, and other information with the CommissionSEC. Our filings We make these documents publicly available, free of charge, on our website at xxx.xxxxxxx.xxx as soon as reasonably practicable after filing such documents with the Commission are available to SEC. You can read our SEC filings, including the public registration statement, on the CommissionSEC’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a partxxxx://xxx.xxx.xxx. You also may also read and copy, at the Commission’s prescribed rates, copy any document we file with the Commission, including the registration statement (and SEC at its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can public reference facility at: Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for further information on the operation of the Public Reference Roompublic reference facilities.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements of Flux Power Holdings, Inc. as of June 30, 2020 and 2019 and for each of the years in the two-year period ended June 30, 2019 and 20182020 incorporated in this prospectus by reference from the Flux Power Holdings, Inc. annual report on Form 10-K for the year ended June 30, 2020 have been audited by Xxxxx Xxxxx US, LLP, (Squar Xxxxxx LLP merged with Xxxxx Xxxxx US, LLP on November 1, 2020) an independent registered public accounting firm, given on as stated in their report thereon, incorporated herein by reference, and have been incorporated in this Prospectus and Registration Statement in reliance upon such report and upon the authority of said such firm as experts in auditing accounting and accountingauditing. We This prospectus supplement and the accompanying prospectus are part of the registration statement on Form S-3 we filed with the Commission a registration statement Securities and Exchange Commission, or SEC, under the Securities Act for the common stock in this offering. This prospectus does Act, and do not contain all of the information set forth in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect Whenever a reference is made in this prospectus supplement or the accompanying prospectus to us any of our contracts, agreements or other documents, the reference may not be complete, and our common stock, we you should refer you to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus supplement and the exhibits that were filed with accompanying prospectus for a copy of such contract, agreement or other document. You may inspect a copy of the registration statement. Statements contained in this prospectus about , including the contents of any contract exhibits and schedules, without charge, at the SEC’s public reference room mentioned below, or any other document that is filed as an exhibit to obtain a copy from the registration statement are not necessarily complete, and we refer you to the full text SEC upon payment of the contract or other document filed as an exhibit to fees prescribed by the registration statementSEC. We file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. You may read, without charge, and copy the documents we file at the SEC’s public reference rooms in Washington, DC. at 000 X Xxxxxx, XX, Xxxx 0000, Xxxxxxxxxx, XX 00000. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the SEC at 0-000-XXX-0000 for further information on the public reference rooms. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those SEC filings are also available to the public on our corporate at no cost from the SEC’s website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomxxxx://xxx.xxx.xxx.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements for the years ended of iBio, Inc. and Subsidiaries as of June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We filed with the Commission a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stockyears then ended, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained incorporated by reference in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statement. We file annual, quarterly, and current reports and other information with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read , have been so included in reliance on the audit report, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, of CohnReznick LLP, an independent registered public accounting firm, incorporated by reference in this prospectus and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, given the authority of that firm as experts in accounting and auditing. We file quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission, or the SEC. You can inspect and copy these reports, proxy statements and other information without charge at the Commissionpublic reference facilities of the SEC at the SEC’s Public Reference Room located at the SEC’s principal office at Room 0000, 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to may obtain information on the operation of this public reference room by calling 0-000-XXX-0000. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the Public Reference Room.SEC and state the address of that site (xxxx://xxx.xxx.xxx). The Registration Statement, including all exhibits and schedules and amendments, has been filed with the SEC through the Electronic Data Gathering Analysis and Retrieval system and is available to the public from the SEC’s web site at xxxx://xxx.xxx.xxx. We also make our annual, quarterly and current reports, proxy statements and other information free of charge on our investor website,xxxxx://xx.xxxxxxx.xxx/sec-filings, as soon as reasonably practicable after we electronically file these materials with, or furnish them to, the SEC. We use our website as a channel of distribution for material company information. Important information, including financial information, analyst presentations, financial news releases, and other material information about us is routinely posted on and accessible at xxxxx://xx.xxxxxxx.xxx/.

EXPERTS. The consolidated financial statements incorporated by reference into this as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013 and management’s assessment of the effectiveness of internal control over financial reporting (which is included in Management’s Report on Internal Control over Financial Reporting) as of December 31, 2013 included in the accompanying prospectus have been so included in reliance on the report of Xxxxxx PricewaterhouseCoopers LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We have filed with the Commission SEC a registration statement on Form N-2, together with all amendments and related exhibits, under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information Act, with respect to our securities offered by this prospectus supplement and the accompanying prospectus. The registration statement contains additional information about us and our common stock, we refer you to the registration statement securities being offered by this prospectus supplement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementaccompanying prospectus. We file annual, quarterly, quarterly and current reports periodic reports, proxy statements and other information with the CommissionSEC under the Exchange Act. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained onYou may inspect and copy these reports, or linked to throughproxy statements and other information, our corporate website or any other website that we may maintain is not part of this prospectus or as well as the registration statement of which this prospectus is supplement and accompanying prospectus form a part. You may also read part and copythe related exhibits and schedules, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located of the SEC at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000-0000. You can call the Commission at 1-800- SEC-0330 to may obtain information on the operation of the Public Reference RoomRoom by calling the SEC at 000-000-0000. The SEC maintains an Internet website that contains reports, proxy and information statements and other information filed electronically by us with the SEC which are available on the SEC’s Internet website at xxxx://xxx.xxx.xxx. Copies of these reports, proxy and information statements and other information may be obtained, after paying a duplicating fee, by electronic request at the following E-mail address: xxxxxxxxxx@xxx.xxx, or by writing the SEC’s Public Reference Section, Washington, D.C. 20549-0102. This prospectus relates to the offer, from time to time, in one or more offerings or series, up to $400,000,000 of shares of our common stock, par value $0.001 per share, preferred stock, par value $0.001 per share, warrants representing rights to purchase shares of our common stock, preferred stock or debt securities, subscription rights or debt securities, which we refer to, collectively, as the “securities.” The preferred stock, debt securities, subscription rights and warrants offered hereby may be convertible or exchangeable into shares of our common stock. We may sell our securities through underwriters or dealers, “at-the-market” to or through a market maker into an existing trading market or otherwise directly to one or more purchasers, including existing stockholders in a rights offering, or through agents or through a combination of methods of sale, including auctions. The identities of such underwriters, dealers, market makers or agents, as the case may be, will be described in one or more supplements to this prospectus. The securities may be offered at prices and on terms to be described in one or more supplements to this prospectus. Although we are not currently authorized to issue shares of our common stock at a price below our net asset value per share, we may seek stockholder approval of this proposal again at a special meeting of stockholders or our next annual meeting of stockholders. Our Board of Directors, subject to its fiduciary duties and regulatory requirements, has the discretion to determine the amount of the discount, and as a result, the discount could be up to 100% of net asset value per share. Sales of common stock at prices below net asset value per share dilute the interests of existing stockholders, have the effect of reducing our net asset value per share and may reduce our market price per share. In the event we offer common stock, the offering price per share will not be less than the net asset value per share of our common stock at the time we make the offering except (1) in connection with a rights offering to our existing stockholders,

EXPERTS. The consolidated financial statements of Galectin Therapeutics, Inc. and subsidiaries as of December 31, 2012 and 2011 and for the years then ended, and the cumulative period ended December 31, 2012, have been incorporated by reference into this prospectus have been so included herein in reliance on upon the report of Xxxxxx XxXxxxxxx LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on and upon the authority of said firm as experts in auditing accounting and accounting. We filed with the Commission a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementauditing. We file annualreports with the SEC on an annual basis using Form 10–K, quarterly, quarterly reports on Form 10–Q and current reports and other information with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. Form 8–K. You may also read and copy, copy any such reports and amendments thereto at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s SECs Public Reference Room located at 000 100 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can 00000 xn official business days during the hours of 10:00 a.m. to 3:00 p.m. Please call the Commission SEC at 1-800- SEC-0330 to obtain 1–800–SEC–0330 for information on the operation of the Public Reference Room. Additionally, the SEC maintains a website that contains annual, quarterly, and current reports, proxy statements, and other information that issuers (including us) file electronically with the SEC. The SECs website address is xxxx://xxx.xxx.xxx. You can also obtain copies of materials we file with the SEC from our Internet website found at xxx.xxxxxxxxxxxxxxxxxxxx.xxx. Our stock is quoted on the NASDAQ Capital Market under the symbol “GALT.” This prospectus supplement and the related prospectus are only part of a registration statement on Form S–3 that we have filed with the SEC under the Securities Act and therefore omits certain information contained in the registration statement. We have also filed exhibits and schedules with the registration statement that are excluded from this prospectus supplement, and you should refer to the applicable exhibit or schedule for a complete description of any statement referring to any contract or other document. You may inspect a copy of the registration statement, including the exhibits and schedules, without charge, at the public reference room or obtain a copy from the SEC upon payment of the fees prescribed by the SEC.

EXPERTS. The consolidated financial statements incorporated in this prospectus by reference into this prospectus from the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 have been so included in reliance on the report of Xxxxxx audited by CohnReznick LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference, which report includes an explanatory paragraph on the Company’s ability to continue as a going concern. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of said such firm as experts in auditing accounting and accountingauditing. We have filed with the Commission a registration statement under on Form S-3 with the Securities Act SEC for the shares of common stock in offered by this offeringprospectus supplement and the accompanying prospectus. This prospectus does supplement and the accompanying prospectus, including the information incorporated by reference herein and therein, do not contain include all of the information contained in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we You should refer you to the registration statement and the its exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementfor additional information. We file annual, quarterlyquarterly and periodic reports, and current reports proxy statements and other information with the CommissionSEC. Our Many of our SEC filings with the Commission are available to the public on from the CommissionSEC’s website at website: xxx.xxx.xxx. Those filings are also We make available free of charge our annual, quarterly and current reports, proxy statements and other information upon request. To request such materials, please contact us at the following address or telephone number: ADMA Biologics, Inc. 000 Xxxxx 00, Xxxxxx, Xxx Xxxxxx 00000, Attention: Xxxxx Xxxx, Executive Vice President and Chief Financial Officer, (000) 000-0000. Exhibits to the public on our corporate website xxxxx.xxxxxxx.xxxdocuments will not be sent, unless those exhibits have specifically been incorporated by reference in this prospectus. The You may also obtain reports, statements or other information that we file with the Commission or SEC by accessing our website at xxx.xxxxxxxxxxxxx.xxx, under the Investors tab, SEC Filings. Information contained onin, or linked to accessible through, our corporate website or any other website that we may maintain is does not constitute a part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomprospectus.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements of India Globalization Capital, Inc. included in our annual report on Form 10-K for the years fiscal year ended June 30March 31, 2019 2020 and 2018March 31, an 2019, have been audited by Xxxxxxx Xxxxxxxx & Associates, independent registered public accounting firmaccountants, as set forth in their reports thereon, included therein, and incorporated herein by reference in this prospectus and elsewhere in the registration statement. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of said firm as experts in auditing accounting and accountingauditing. We filed with Xxxxxx Frome Xxxxxxx LLP, New York, New York, as our counsel, will pass upon certain legal matters, including the Commission a registration statement under legality of the Securities Act securities offered by this prospectus and any prospectus supplement. If the securities are distributed in an underwritten offering, certain legal matters will be passed upon for the common stock in this offering. This prospectus does not contain all of the information underwriters by counsel identified in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this applicable prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementsupplement. We file annualreports, quarterly, and current reports proxy statements and other information documents with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a partSEC. You may also read and copy, at the Commission’s prescribed rates, copy any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the CommissionSEC’s Public Reference Room located public reference room at 000 X Xxxxxx, X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000, subject to restrictions that may be imposed from time to time as a result of the COVID-19 pandemic. You can should call the Commission at 10-800- SEC-0330 to obtain 000-XXX-0000 for more information on the operation of the Public Reference Roompublic reference room, including any restrictions imposed as a result of the COVID-19 pandemic. Our SEC filings are also available to you on the SEC's Internet site at xxxx://xxx.xxx.xxx. The SEC’s Internet site contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. This prospectus is part of a registration statement on Form S-3 that we filed with the SEC. The registration statement contains more information than this prospectus regarding us and our common stock, including certain exhibits and schedules. You can obtain a copy of the registration statement from the SEC at the address listed above or from the SEC’s Internet site. Our Internet address is xxx.xxxxxx.xx. The information on our Internet website is not incorporated by reference in this prospectus.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements of Verb Technology Company, Inc. as of and for the years ended June 30December 31, 2019 and 20182018 appearing in this prospectus and registration statement of which this prospectus is a part have been audited by Xxxxxxxx & Company, P.A., an independent registered public accounting firm, given on as stated in its report thereon, included therein, and are included in reliance upon such report and upon the authority of said such firm as experts in auditing accounting and accounting. We filed with the Commission a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementauditing. We file annual, quarterly, quarterly and current reports reports, proxy statements, and other information with the CommissionSEC. The SEC maintains a website that contains these reports, proxy and information statements, and other information we file electronically with the SEC. Our filings with the Commission are available to free of charge at the public on the CommissionSEC’s website at xxx.xxx.xxx. Those filings You can obtain copies of any of the documents incorporated by reference in this prospectus from us, or as described above, through the SEC’s website. Documents incorporated by reference are available from us, without charge, excluding all exhibits unless specifically incorporated by reference in the documents. You may obtain documents incorporated by reference in this prospectus by writing to us at the following address: 000 Xxxxx Xxxx Xxxx Xxxxx, Xxxxxxxx Xxxx, Xxxx 00000, Attention: Investor Relations, by emailing us at xxxx@xxxx.xxxx, or by calling us at 000.000.0000. We also available to the public maintain a section on our corporate website, xxxxx://xxx.xxxx.xxxx/investor-relations/sec-filings, through which you can obtain copies of the documents that we have filed with the SEC. We use our website xxxxx.xxxxxxx.xxxas a channel of distribution for material company information. Important information, including financial information, analyst presentations, financial news releases, and other material information about us is routinely posted on and accessible at xxxxx://xxx.xxxx.xxxx. The information we file with the Commission or contained set forth on, or linked to throughaccessible from, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomprospectus.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements of IGC Pharma, Inc. included in our annual report on Form 10-K for the years fiscal year ended June 30March 31, 2019 2023, and 2018March 31, an 2022, have been audited by Xxxxxxx Xxxxxxxx & Associates, independent registered public accounting firmaccountants, as set forth in their reports thereon, included therein, and incorporated herein by reference in this prospectus supplement and elsewhere in the registration statement. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of said firm as experts in auditing accounting and accountingauditing. We file reports, proxy statements, and other documents with the SEC. You may read and copy any document we file at the SEC’s public reference room at 000 X Xxxxxx, X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000. You should call 0-000-XXX-0000 for more information on the operation of the public reference room. Our SEC filings are also available to you on the SEC's Internet site at xxxx://xxx.xxx.xxx. The SEC’s Internet site contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. This prospectus supplement constitutes a part of a registration statement on Form S-3 that we have filed with the Commission a registration statement SEC under the Securities Act for the common stock in this offeringAct. This prospectus supplement does not contain all of the information set forth in the registration statement and the exhibits and schedule that were filed statement, certain parts of which are omitted in accordance with the registration statementrules and regulations of the SEC. For further information with respect to about us and our common stocksecurities, we refer you to the registration statement and the accompanying exhibits that were filed with and schedules. The registration statement may be inspected at the registration statementPublic Reference Room maintained by the SEC at the address set forth above. Statements contained in this prospectus about supplement regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete. In each instance, and we refer you reference is made to the full text copy of the such contract or other document filed as an exhibit to the registration statement. We file annual, quarterly, and current reports and other information with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website each statement is qualified in all respects by that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomreference.

EXPERTS. The consolidated financial statements incorporated in this prospectus by reference into this prospectus from our Annual Report on Form 10-K for the years ended December 31, 2020 and 2019, and for each of the years in the period ended December 31, 2020, have been so included incorporated in reliance on the report of Xxxxxx Xxxxxx, LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting. We The consolidated financial statements of Enertec, as of December 31, 2020 and December 31, 2019, and for the year ended December 31, 2020 incorporated by reference in this prospectus have been so incorporated in reliance on the report of BDO XXX XXXX, an independent registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting. This prospectus supplement and the accompanying prospectus are part of the registration statement on Form S-3 we filed with the Commission a registration statement SEC under the Securities Act for the common stock in this offering. This prospectus does Act, and do not contain all of the information set forth in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect Whenever a reference is made in this prospectus supplement or the accompanying prospectus to us any of our contracts, agreements or other documents, the reference may not be complete, and our common stock, we you should refer you to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus supplement and the exhibits that were filed with accompanying prospectus for a copy of such contract, agreement or other document. You may inspect a copy of the registration statement. Statements contained in this prospectus about , including the contents of any contract exhibits and schedules, without charge, at the SEC's public reference room mentioned below, or any other document that is filed as an exhibit to obtain a copy from the registration statement are not necessarily complete, and we refer you to the full text SEC upon payment of the contract or other document filed as an exhibit to fees prescribed by the registration statementSEC. We file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. You may read, without charge, and copy the documents we file at the SEC’s public reference rooms in Washington, D.C. at 000 X Xxxxxx, XX, Xxxx 0000, Xxxxxxxxxx, XX 00000. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the SEC at 0-000-XXX-0000 for further information on the public reference rooms. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those SEC filings are also available to the public on our corporate at no cost from the SEC’s website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomxxxx://xxx.xxx.xxx.

EXPERTS. The consolidated financial statements incorporated in this prospectus by reference into this prospectus from Xenetic Biosciences, Inc.’s and subsidiaries’ Annual Report on Form 10-K , as amended, have been so included in reliance on the report of Xxxxxx audited by Marcum LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, as stated in their report, which are incorporated herein by reference. Such consolidated financial statements have been so incorporated in reliance upon the report of such firm given on the upon their authority of said firm as experts in auditing accounting and accountingauditing. We have filed with the Commission a registration statement under statement, of which this prospectus is a part, covering the Securities Act for the common stock in securities offered hereby. As allowed by SEC rules, this offering. This prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedule that were filed with the registration statementthereto. For further information with respect to us and our common stock, we We refer you to the registration statement and the exhibits that were filed with thereto for further information. This prospectus is qualified in its entirety by such other information. Copies of the registration statement. Statements contained in this prospectus about , including the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, exhibits and we refer you to the full text of the contract or other document filed as an exhibit schedules to the registration statement. We file annual, quarterly, and current reports and other information with the Commission. Our filings with the Commission are available to may be examined without charge at the public on reference room of the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained onSEC, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxx 0000, Xxxxxxxxxx, X.X. XX 00000. You can call Information about the Commission operation of the public reference room may be obtained by calling the SEC at 1-800- SEC-0330 SEC-0330. Copies of all or a portion of the registration statement can be obtained from the public reference room of the SEC upon payment of prescribed fees. Our SEC filings, including our registration statement, are also available to obtain information you on the operation SEC’s website at xxx.xxx.xxx. We file reports, proxy statements and other information with the SEC as required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Those reports, proxy statements and other information are available for inspection and copying at the Public Reference RoomRoom and on the SEC’s website referred to above. We maintain a website on the Internet with the address xxxxx.xxxxxxxxxx.xxx. We are not incorporating by reference into this prospectus the information on our website, and you should not consider our website to be a part of this prospectus.

EXPERTS. The consolidated financial statements of Albireo Pharma, Inc. at December 31, 2016, and for the year then ended, incorporated by reference into this prospectus have been so included in reliance on the report of Xxxxxx LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We filed with the Commission a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statement. We file annual, quarterly, and current reports and other information with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is forms a partpart have been audited by Xxxxx & Young LLP (United States), independent registered public accounting firm, and at December 31, 2015, and for the year then ended, by Xxxxx & Young LLP (United Kingdom), independent registered public accounting firm, as set forth in their respective reports thereon incorporated by reference herein, and are included in reliance upon such reports given on the authority of such firms as experts in accounting and auditing. We are subject to the reporting requirements of the Exchange Act and file annual, quarterly and current reports, proxy statements and other information with the SEC. You may also read and copycopy these reports, proxy statements and other information at the CommissionSEC’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located public reference facilities at 000 X Xxxxxx, X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for more information on about the operation of the Public Reference Roompublic reference facilities. SEC filings are also available at the SEC’s web site at xxxx://xxx.xxx.xxx. This prospectus is only part of a registration statement on Form S-3 that we have filed with the SEC under the Securities Act of 1933, as amended, and therefore omits certain information contained in the registration statement. We have also filed exhibits and schedules with the registration statement that are excluded from this prospectus, and you should refer to the applicable exhibit or schedule for a complete description of any statement referring to any contract or other document. You may inspect a copy of the registration statement, including the exhibits and schedules, without charge, at the public reference room or obtain a copy from the SEC upon payment of the fees prescribed by the SEC. We also maintain a website at xxx.xxxxxxxxxxxxx.xxx, through which you can access our SEC filings. The information set forth on our website is not part of this prospectus.

EXPERTS. The consolidated financial statements incorporated in this prospectus supplement by reference into this prospectus from Xenetic Biosciences, Inc.’s and subsidiaries’ Annual Report on Form 10-K , as amended, have been so included in reliance on the report of Xxxxxx audited by Marcum LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, as stated in their report, which are incorporated herein by reference. Such consolidated financial statements have been so incorporated in reliance upon the report of such firm given on the upon their authority of said firm as experts in auditing accounting and accountingauditing. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at xxx.xxx.xxx. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act can also be accessed free of charge by linking directly from our website at xxx.xxxxxxxxxx.xxx. These filings will be available as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. We have filed with the Commission SEC a registration statement under the Securities Act for relating to the common stock in this offeringoffering of these securities. The registration statement, including the exhibits attached thereto, contains additional relevant information about us and the securities. This prospectus does supplement and the accompanying prospectus do not contain all of the information set forth in the registration statement. You can obtain a copy of the registration statement, at prescribed rates, from the SEC at the address listed above. The registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect documents referred to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statement. We file annual, quarterly, and current reports and other information with the Commission. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings below under “Incorporation by Reference” are also available to the public on our corporate Internet website, xxx.xxxxxxxxxx.xxx. We are not incorporating by reference into this prospectus supplement the information on our website, and you should not consider our website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not be a part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomprospectus.

EXPERTS. The financial statements and management’s assessment of the effectiveness of internal control over financial reporting (which is included in the Report of Management on Internal Controls over Financial Reporting) incorporated in this Prospectus by reference into this prospectus to the Annual Report on Form 10-K for the year ended December 31, 2018 have been so included incorporated in reliance on the report of Xxxxxx PricewaterhouseCoopers LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. We filed with the Commission are a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement public company and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statement. We file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those SEC filings are also available to the public at the SEC’s website at xxx.xxx.xxx. We also make available free of charge through our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as well as our corporate definitive proxy statement and Section 16 reports on Forms 3, 4 and 5. Our website xxxxx.xxxxxxx.xxxaddress is xxx.XxxxxxxxxXxxxxxxxxx.xxx. The However, the information we file with the Commission or contained located on, or linked to throughaccessible from, our corporate website or any other website that we may maintain is not, and shall not be deemed to be, except as described below, a part of this prospectus or any accompanying prospectus supplement or incorporated into any other filings that we make with the SEC. This prospectus comprises only part of a registration statement on Form S-3 that we have filed with the SEC under the Securities Act and, therefore, omits some of the information contained in the registration statement. We have also filed exhibits and schedules to the registration statement which are excluded from this prospectus, and you should refer to the applicable exhibit or schedule for a complete description of which this prospectus is a partany statement referring to any contract or other document. You may also read and copy, at inspect or obtain a copy of the Commission’s prescribed rates, any document we file with the Commissionregistration statement, including the registration statement (exhibits and its exhibits) of which this prospectus is a partschedules, at as described in the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomprevious paragraph.

EXPERTS. The consolidated financial statements and schedules of UMH Properties, Inc. as of December 31, 2022 and 2021 and for each of the three years in the period ended December 31, 2022, included in our Annual Report on Form 10-K for the year ended December 31, 2022, have been incorporated by reference into this prospectus have been so included herein in reliance on upon the report of Xxxxxx PKF O’Connor Davies, LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an our independent registered public accounting firm, given on incorporated by reference herein, and upon the authority of said firm as experts in auditing accounting and accountingauditing. We have filed with the Commission SEC a shelf registration statement under the Securities Act for with respect to the common stock in securities offered hereunder. As permitted by the rules and regulations of the SEC, this offering. This prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us regarding our company and our common stocksecurities, we please refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any contracts, agreements and other document that is documents filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit exhibits to the registration statement. We Additionally, we file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. Our filings with You may read and copy all or any portion of the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information registration statement or any other materials that we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, SEC at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the CommissionSEC’s Public Reference Room located at 000 X Xxxxxx100 F Street, X.X.N.E., XxxxxxxxxxWashington, X.X. 00000D.C. 20549. You can Please call the Commission SEC at 1-800- 800-SEC-0330 to obtain for further information on the operation of the Public Reference Roompublic reference rooms. Our SEC filings, including the registration statement, are also available to you on the SEC’s website (http://www.sec.gov). We also have a website (www.umh.reit) through which you may access our recent SEC filings. Information contained on our website is not a part of this prospectus. In addition, you may look at our SEC filings at the offices of the NYSE which is located at 20 Broad Street, New York, New York 10005. Our SEC filings are available at the NYSE because our Common Stock and Series D Preferred Stock are listed and traded on the NYSE. Our Common Stock is also listed and traded on the TASE.

EXPERTS. The financial statements incorporated by reference into this prospectus have been so included in reliance on consolidated balance sheets of Matinas BioPharma Holdings, Inc. and Subsidiaries (the report “Company”) as of Xxxxxx LLP, related to the consolidated financial statements for the years ended June 30December 31, 2019 and 2018, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2019, and the effectiveness of the Company’s internal control over financial reporting have been audited by EisnerAmper LLP, an independent registered public accounting firm. Such financial statements and the effectiveness of the Company’s internal control over financial reporting, given have been incorporated herein by reference to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, and have been so incorporated in reliance on the reports (which contain an adverse opinion on the effectiveness of the Company’s internal control over financial reporting because of material weaknesses) of such firm given upon their authority of said firm as experts in auditing accounting and accountingauditing. We filed with the Commission This prospectus constitutes a part of a registration statement on Form S-3 filed under the Securities Act for Act. As permitted by the common stock in SEC’s rules, this offering. This prospectus does and any prospectus supplement, which form a part of the registration statement, do not contain all of the information that is included in the registration statement and the exhibits and schedule that were filed with the registration statement. For further You will find additional information with respect to about us in the registration statement. Any statements made in this prospectus or any prospectus supplement concerning legal documents are not necessarily complete and our common stock, we refer you should read the documents that are filed as exhibits to the registration statement and the exhibits that were or otherwise filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text SEC for a more complete understanding of the contract document or other document filed as an exhibit to the registration statementmatter. We file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. You may read, without charge, and copy the documents we file at the SEC’s public reference rooms in Washington, D.C. at 000 X Xxxxxx, XX, Xxxx 0000, Xxxxxxxxxx, XX 00000. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the SEC at 0-000-XXX-0000 for further information on the public reference rooms. Our filings with the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those SEC filings are also available to the public on our corporate at no cost from the SEC’s website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomxxxx://xxx.xxx.xxx.

EXPERTS. The financial audited consolidated balance sheets as of September 30, 2014, and the related consolidated statements of income and comprehensive income, shareholders’ equity, and cash flows for the year ended September 30, 2014 incorporated herein by reference into this prospectus have from the Company’s Annual Reports on Form 10-K has been so included in reliance on the report of Xxxxxx audited by Xxxxx & Chia, LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, as stated in its report, which is incorporated by reference and has been so incorporated in reliance upon the report of such firm given on the upon its authority of said firm as experts in auditing accounting and accountingauditing. The audited consolidated balance sheets as of September 30, 2013, and the related consolidated statements of income and comprehensive income, shareholders’ equity, and cash flows for the year ended September 30, 2013 incorporated herein by reference from the Company’s Annual Reports on Form 10-K has been audited by Xxxxxx and Company, Inc. an independent registered public accounting firm, as stated in its report, which is incorporated by reference and has been so incorporated in reliance upon the report of such firm given upon its authority as experts in accounting and auditing. We have filed with the Commission a registration statement under on Form S-3 with the Securities Act SEC for the common stock in securities we are offering by this offeringprospectus. This prospectus does not contain include all of the information contained in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we You should refer you to the registration statement and its exhibits for additional information. We will provide to each person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the exhibits information that were filed has been incorporated by reference in the prospectus but not delivered with the registration statementprospectus. Statements contained in We will provide this prospectus about the contents information upon oral or written request, free of any contract charge. Any requests for this information should be made by calling or any other document that is filed as an exhibit sending a letter to the registration statement are not necessarily complete, and we refer you to the full text Secretary of the contract or other document filed as an exhibit to Company, c/o LiveDeal, Inc., at the registration statementCompany’s office. We are required to file annualannual and quarterly reports, quarterlycurrent reports, and current reports proxy statements, and other information with the CommissionSEC. Our filings We make these documents publicly available, free of charge, on our website at xxx.xxxxxxx.xxx as soon as reasonably practicable after filing such documents with the Commission are available to SEC. You can read our SEC filings, including the public registration statement, on the CommissionSEC’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a partxxxx://xxx.xxx.xxx. You also may also read and copy, at the Commission’s prescribed rates, copy any document we file with the Commission, including the registration statement (and SEC at its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can public reference facility at: Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for further information on the operation of the Public Reference Roompublic reference facilities.

EXPERTS. The consolidated financial statements as of December 31, 2014 and 2013, and for each of the two years in the period ended December 31, 2014, and management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2014, incorporated by reference into in this prospectus supplement have been so included incorporated in reliance on the report reports of Xxxxxx BDO USA, LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an independent registered public accounting firm, (the report on the consolidated financial statements contains an explanatory paragraph regarding the Company’s ability to continue as a going concern) incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting. We This prospectus supplement and the accompanying prospectus are part of a registration statement on Form S-3 that we filed with the Commission a registration statement SEC under the Securities Act for the common stock in this offeringAct. This prospectus does supplement and the accompanying prospectus do not contain all of the information included in the registration statement and the exhibits and schedule that were filed with the registration statement. We have omitted certain parts of the registration statement in accordance with the rules and regulations of the SEC. For further information with respect to us and our common stockinformation, we refer you to the registration statement statement, including its exhibits and the exhibits that were filed with the registration statementschedules. Statements contained in this prospectus supplement and the accompanying prospectus about the provisions or contents of any contract contract, agreement or any other document that is filed as an exhibit referred to the registration statement are not necessarily complete, and we . Please refer you to the full text actual exhibit for a more complete description of the contract or other document filed as an exhibit to the registration statementmatters involved. We file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. Our filings with SEC filings, including the Commission registration statement and exhibits, are available to the public on at the CommissionSEC’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a partxxxx://xxx.xxx.xxx. You may also read read, without charge, and copycopy the documents we file, at the CommissionSEC’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located public reference rooms at 000 X Xxxxxx, X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for further information on the operation public reference rooms. We maintain an Internet site at xxx.xxxxxxxxxxxx.xxx. We have not incorporated by reference into this prospectus supplement or the accompanying prospectus the information on our website, and you should not consider any of the Public Reference Roominformation posted on or hyper-linked to our website to be a part of this prospectus supplement or the accompanying prospectus.

EXPERTS. The consolidated financial statements incorporated in this prospectus supplement by reference into this prospectus have been so included in reliance from the Company’s Annual Report on the report of Xxxxxx LLP, related to the consolidated financial statements Form 10-K for the years year ended June 30December 31, 2019 and 2018the effectiveness of our internal control over financial reporting as of December 31, 2019 have been audited by CohnReznick LLP, an independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of said such firm as experts in auditing accounting and accountingauditing. We have filed with the Commission a registration statement under on Form S-3 with the Securities Act SEC for the shares of common stock in offered by this offeringprospectus supplement and the accompanying prospectus. This prospectus does supplement and the accompanying prospectus, including the information incorporated by reference herein and therein, do not contain include all of the information contained in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we You should refer you to the registration statement and the its exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statementfor additional information. We file annual, quarterlyquarterly and periodic reports, and current reports proxy statements and other information with the CommissionSEC. Our Many of our SEC filings with the Commission are available to the public on from the CommissionSEC’s website at website: xxx.xxx.xxx. Those filings are also We make available free of charge our annual, quarterly and current reports, proxy statements and other information upon request. To request such materials, please contact us at the following address or telephone number: ADMA Biologics, Inc. 000 Xxxxx 00, Xxxxxx, Xxx Xxxxxx 00000, Attention: Xxxxx Xxxx, Executive Vice President and Chief Financial Officer, (000) 000-0000 .. Exhibits to the public on our corporate website xxxxx.xxxxxxx.xxxdocuments will not be sent, unless those exhibits have specifically been incorporated by reference in this prospectus. The You may also obtain reports, statements or other information that we file with the Commission or SEC by accessing our website at xxx.xxxxxxxxxxxxx.xxx, under the Investors tab, SEC Filings. Information contained onin, or linked to accessible through, our corporate website or any other website that we may maintain is does not constitute a part of this prospectus or the registration statement of which this any accompanying prospectus is a part. You may also read and copy, at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the Commission’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can call the Commission at 1-800- SEC-0330 to obtain information on the operation of the Public Reference Roomsupplement.

EXPERTS. The consolidated financial statements and schedules of UMH Properties, Inc. as of December 31, 2022 and 2021 and for each of the three years in the period ended December 31, 2022, included in our Annual Report on Form 10-K for the year ended December 31, 2022, have been incorporated by reference into this prospectus have been so included herein in reliance on upon the report of Xxxxxx PKF X’Xxxxxx Xxxxxx, LLP, related to the consolidated financial statements for the years ended June 30, 2019 and 2018, an our independent registered public accounting firm, given on incorporated by reference herein, and upon the authority of said firm as experts in auditing accounting and accountingauditing. We have filed with the Commission SEC a shelf registration statement under the Securities Act for with respect to the common stock in securities offered hereunder. As permitted by the rules and regulations of the SEC, this offering. This prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us regarding our company and our common stocksecurities, we please refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any contracts, agreements and other document that is documents filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit exhibits to the registration statement. We Additionally, we file annual, quarterly, quarterly and current reports reports, proxy statements and other information with the CommissionSEC. Our filings with You may read and copy all or any portion of the Commission are available to the public on the Commission’s website at xxx.xxx.xxx. Those filings are also available to the public on our corporate website xxxxx.xxxxxxx.xxx. The information registration statement or any other materials that we file with the Commission or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, SEC at the Commission’s prescribed rates, any document we file with the Commission, including the registration statement (and its exhibits) of which this prospectus is a part, at the CommissionSEC’s Public Reference Room located at 000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. You can Please call the Commission SEC at 10-800- SEC-0330 to obtain 000-XXX-0000 for further information on the operation of the Public Reference Roompublic reference rooms. Our SEC filings, including the registration statement, are also available to you on the SEC’s website (xxxx://xxx.xxx.xxx). We also have a website (xxx.xxx.xxxx) through which you may access our recent SEC filings. Information contained on our website is not a part of this prospectus. In addition, you may look at our SEC filings at the offices of the NYSE which is located at 00 Xxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000. Our SEC filings are available at the NYSE because our Common Stock and Series D Preferred Stock are listed and traded on the NYSE. Our Common Stock is also listed and traded on the TASE.